Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimising adalimumab treatment in psoriasis with concomitant methotrexate
2013-004918-18Phase 4Terminated
- Sponsor
- Academic Medical Center
- Start
- Dec 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of adalimumab in psoriasis (2 arms), sponsored by Academic Medical Center. Primary endpoint: Drug survival at one year. Started Dec 2013; status: terminated.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2013-004918-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004918-18.